Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/20/2014US20140341991 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/20/2014US20140341990 Controlled Release Formulations of Nisoldipine
11/20/2014US20140341989 Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
11/20/2014US20140341988 Orally dispersible drug formulations
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/20/2014US20140341985 Method of reducing somnolence in patients treated with tizanidine
11/20/2014US20140341984 Tamper resistant pharmaceutical formulations
11/20/2014US20140341979 Nanodrug targeting protein geranylgeranylation
11/20/2014US20140341976 Compositions and methods for inhibiting "stimulator of interferon gene" -dependent signalling
11/20/2014US20140341972 Method to induce neovascular formation and tissue regeneration
11/20/2014US20140341968 Intraocular Drug Delivery Systems
11/20/2014US20140341966 Steroid-containing sustained release intraocular implants and related methods
11/20/2014US20140341940 Immunomodulator for the treatment of cancerous tumors in the epithelial tissue lining surfaces inside or outside body organs
11/20/2014US20140341930 Systems and Methods for Diminishing Cell Growth and Inducing Selective Killing of Target Cells
11/20/2014US20140341922 Method for Overcoming Tolerance to Targeted Anti-Cancer Agent
11/20/2014US20140341917 Anti-pd-l1 antibodies and uses thereof
11/20/2014US20140341916 Therapeutic combinations and methods of treating melanoma
11/20/2014US20140341902 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
11/20/2014US20140341901 Compositions and methods of use for antibodies of dickkopf-1
11/20/2014US20140341894 Certain chemical entities, compositions and methods
11/20/2014US20140341893 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
11/20/2014US20140341891 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES
11/20/2014US20140341884 Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain
11/20/2014US20140341876 Method for the treatment of pulmonary disease and method of producing proteins of use therein
11/20/2014US20140341867 Treatment of stroke using isolated placental cells
11/20/2014US20140341857 Combination of oncolytic adenoviruses with histone deacetylase inhibitors
11/20/2014US20140341855 Reuterin-Producing Lactobacillus Brevis
11/20/2014US20140341853 Bacteria-Mediated Therapy for Cancer
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/20/2014US20140341849 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
11/20/2014US20140341848 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
11/20/2014US20140341847 4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
11/20/2014US20140341845 Methods and systems for treating cell proliferation related disorders
11/20/2014US20140341842 Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
11/20/2014US20140341837 Ferrate and Povidone Iodine (PI) Composition
11/20/2014US20140341815 Delivery system for remote treatment of an animal
11/20/2014US20140341803 Stable nanoemulsions useful in the treatment of cancer
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/20/2014US20140339122 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/18/2014US8889906 Tetralin and indane derivatives and uses thereof
11/18/2014US8889902 Acetylsalicylic acid salts
11/18/2014US8889894 Compounds for use in therapy
11/18/2014US8889881 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor
11/18/2014US8889880 Processes for preparing tubulysins
11/18/2014US8889876 Histone deacetylase inhibitors and uses thereof
11/18/2014US8889875 Pyridyl derivatives as CFTR modulators
11/18/2014US8889874 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889870 Kinase inhibitors
11/18/2014US8889868 CC-1065 analogs and their conjugates
11/18/2014US8889866 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
11/18/2014US8889862 2-amino-4-arylthiazole compounds as TRPA1 antagonists
11/18/2014US8889861 Crystalline forms of a purine derivative
11/18/2014US8889856 Tetrahydropyrrolothiazine compounds
11/18/2014US8889844 Nucleic acid for treatment or prevention of immunodeficiency virus infection
11/18/2014US8889842 Triterpene saponins, methods of synthesis, and uses thereof
11/18/2014US8889840 Vascular leakage inhibitor
11/18/2014US8889745 Fibrous calcium pyrophosphate particles and methods of making and using same
11/18/2014US8889743 Inhibition of filovirus entry into cells and uses thereof
11/18/2014US8889742 Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury
11/18/2014US8889741 Cycloalkane derivatives
11/18/2014US8889740 Composition and method for treating neurological disease
11/18/2014US8889739 Use of trans-palmitoleate in identifying and treating metabolic disease
11/18/2014US8889738 Amido-amine polymer compositions
11/18/2014US8889737 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
11/18/2014US8889736 Formulations for the treatment of pain
11/18/2014US8889735 Method for treating asthenopia
11/18/2014US8889734 Process for the preparation of dronedarone
11/18/2014US8889733 Artonin I to treat resistant infectious Staphylococcus aureus
11/18/2014US8889732 Fused heterocyclic compounds and thrombopoietin receptor activators
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889729 Compositions for treating amyloid associated diseases
11/18/2014US8889728 Stable pharmaceutical compositions of carvedilol
11/18/2014US8889727 Topical antifungal agent
11/18/2014US8889726 Chemica compounds
11/18/2014US8889724 Tetrazole compounds for reducing uric acid
11/18/2014US8889723 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissues
11/18/2014US8889720 Non-flushing niacin analogues, and methods of use thereof
11/18/2014US8889719 Phenylamino isonicotinamide compounds
11/18/2014US8889718 Thiazole derivatives
11/18/2014US8889716 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/18/2014US8889715 Substituted pyridoxine-lactam carboxylate salts
11/18/2014US8889714 3,4-substituted piperidine derivatives as renin inhibitors
11/18/2014US8889713 N-substituted tetrahydroisoquinoline benzamides/benzene sulfonamides as anti-cancer agents
11/18/2014US8889712 IAP antagonists
11/18/2014US8889711 Pyrazolopyridine derivatives as anticancer agent
11/18/2014US8889710 Parasiticidal dihydroisoxazole compounds
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889707 Treatment of addiction
11/18/2014US8889706 Soluble mTOR complexes and modulators thereof
11/18/2014US8889705 Noscapine analogs and their use in treating cancers
11/18/2014US8889703 Inhibitors of beta-secretase
11/18/2014US8889702 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
11/18/2014US8889701 Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889699 5-fluorouracil derivative
11/18/2014US8889698 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2014US8889697 Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 7860